BF
ANVS icon

BOK Financial’s Annovis Bio ANVS Stock Holding History

BOK Financial’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24K Buy
+555
New +$1.52K ﹤0.01% 1017
2025
Q4 		– Sell
-555
Closed -$1.15K – 1010
2025
Q3 		$1.15K Hold
555
– – ﹤0.01% 1074
2025
Q2 		$1.2K Hold
555
– – ﹤0.01% 1071
2025
Q1 		$833 Hold
555
– – ﹤0.01% 1191
2024
Q4 		$2.71K Hold
555
– – ﹤0.01% 1109
2024
Q3 		$4.45K Buy
+555
New +$5.2K ﹤0.01% 1075

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

BOK Financial's ANVS Position: Q1 2026 in Review

BOK Financial opened a new position in Annovis Bio (ANVS) in Q1 2026: 555 shares worth $1.24K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings. This is a return to the name: BOK Financial previously reported a position in ANVS as recently as Q3 2025.

BOK Financial first reported a position in ANVS in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.45K in Q3 2024. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • BOK Financial held 555 shares of Annovis Bio worth $1.24K as of Q1 2026.
  • Annovis Bio was a new BOK Financial position in Q1 2026.
  • Annovis Bio made up ﹤0.01% of BOK Financial's portfolio in Q1 2026, its #1017 holding.
  • BOK Financial first reported a position in Annovis Bio in Q3 2024 and has held it in 6 quarters since.
  • BOK Financial's Annovis Bio position peaked at $4.45K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.